Unjha Formulations opened lower at ₹27.00, compared with its previous close of ₹28.25. In the last trading session on 12 Nov 2026, the stock traded between ₹27.00 and ₹28.20, with an average traded price of ₹27.42. It showed a sideways intraday trend.
An investment of ₹10,000 made 5 years ago in Unjha Formulations is now worth
₹ 27,566.00
Giving a profit of
₹ 17,566.00 (175.66%)
Note: Past profits do not guarantee future returns.
No analyst rating data available.
Today's Change
-0.05 (-0.18%)
Day High
₹28.20
Day Low
₹27.00
Day Open
₹27.00
Prev Close
₹28.25
Volume
573
Value Traded
₹0.00 Cr
1W Return
1.15%
1M Return
-16.81%
3M Return
4.06%
6M Return
34.29%
1Y Return
9.56%
Market Cap (₹ Cr.)
13
PE Ratio
76.30
PB Ratio
2.81
Dividend Yield
-
ROE
18.34%
ROCE
25.02%
Book Value (₹)
10.07
Face Value (₹)
10.00
EPS (TTM)
-
Industry PE
-
Beta
-
Debt to Equity
-
1 Week
1.15%
6 Weeks
-
1 Month
-16.81%
3 Months
4.06%
9 Months
21.08%
No data available.
Unjha Formulations Q2FY27 Results: Net profit falls 37.6% YoY to ₹51.01 lacs
Unjha Formulations reported Q2FY27 net profit of ₹51.01 lacs, down from ₹81.78 lacs in Q2FY26. Total income from operations rose to ₹440.69 lacs in Q2FY27 from ₹434.74 lacs in Q2FY26. H1FY27 net profit declined to ₹66.70 lacs from ₹120.78 lacs in H1FY26. Total assets as at September 30, 2026 stood at ₹629.30 lacs, up from ₹551.04 lacs as at March 31, 2026. Net cash from operating activities fell to ₹8.28 lacs in H1FY27 from ₹103.99 lacs in H1FY26.
7 days agoUnjha Formulations files FY26 annual results with BSE
Unjha Formulations filed FY26 audited results with BSE on September 8, 2026. Financial statements cover the period ending March 31, 2026. AGM was held on August 14, 2026 to approve the accounts. No specific revenue or profit figures disclosed in this notice.
2mo agoUnjha Formulations shareholders approve FY26 results, appoint Krutiben Patel as MD
Unjha Formulations Limited concluded its 32nd AGM on August 14, 2026, with shareholders approving the FY26 audited financials. Key governance changes included the reappointment of Chairperson Jashodaben S. Patel and the new appointment of Krutiben M. Patel as Managing Director for three years. Related party transactions for FY27 were also approved.
3mo agoUnjha Formulations Q1 Results: Net profit rises to ₹15.69 lakh
Unjha Formulations Limited posted a net profit of ₹15.69 lakh in Q1FY27, reversing a loss of ₹74.28 lakh from Q4FY26. Revenue remained stable at ₹330.75 lakh, while total expenses fell to ₹314.98 lakh due to reduced employee benefits and favorable inventory adjustments. The results were approved by the Board on August 3, 2026.
3mo agoUnjha Formulations sets Aug 7 cut-off for e-voting at 32nd AGM
Unjha Formulations Ltd has set August 7, 2026, as the cut-off date for e-voting eligibility at its 32nd AGM. Voting occurs from August 11 to 13 via CDSL. The AGM itself is held on August 14, 2026.
3mo agoUnjha Formulations files annual report, sets AGM for Aug 14
Unjha Formulations has filed its 32nd Annual Report for FY26 with stock exchanges, complying with SEBI regulations. The company scheduled its 32nd AGM for August 14, 2026, to consider financial accounts. E-voting is available from August 11 to 13, with book closure from August 8 to 14.
3mo ago| Stock | LTP | Change % | Market Cap (Cr.) | PE | 1Y Return |
|---|---|---|---|---|---|
| ₹1,899.30 | +0.76% | ₹4,55,705.69 | 41.20 | +9.65% | |
| ₹11,495.00 | +0.09% | ₹3,05,156.13 | 90.40 | +76.30% | |
| ₹4,685.20 | -0.89% | ₹1,78,209.95 | 85.50 | +22.50% | |
| ₹2,427.00 | +1.13% | ₹1,31,133.78 | 97.10 | +145.34% | |
| ₹1,204.50 | -0.12% | ₹1,20,149.34 | 28.00 | +26.60% | |
| ₹1,388.30 | +0.12% | ₹1,15,878.66 | 42.00 | +12.91% | |
| ₹1,409.80 | +0.11% | ₹1,13,891.88 | 39.90 | -7.21% | |
| ₹2,663.30 | +0.94% | ₹1,10,006.30 | 48.10 | +17.33% | |
| ₹1,808.90 | +0.09% | ₹1,04,080.11 | 26.00 | +52.83% | |
| ₹2,019.10 | +0.20% | ₹92,331.42 | 17.60 | -0.73% | |
| ₹2,639.00 | -0.78% | ₹74,479.09 | 51.60 | +42.82% | |
| ₹5,194.00 | -2.04% | ₹62,102.06 | 30.50 | -9.94% |
An investment of ₹10,000 made 5 years ago in Unjha Formulations is now worth
₹ 27,566.00
Giving a profit of
₹ 17,566.00 (175.66%)
Note: Past profits do not guarantee future returns.
